Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
10.1161/CIRCULATIONAHA.108.808675 3 BanerjeeR.EvandeR.KabilO.OjhaS.TaokaS
Phase 3 data from the ATTAIN-1 trial, which evaluated 3,127 adults with obesity over 72 weeks, showed a mean weight loss of 11.2%, with more than half of participants achieving at least 10% body weight reduction
Is Tirzepatide Treatment Right For You Tirzepatide treatment may be suitable for a variety of individuals, including: Those with Type 2 Diabetes Tirzepatide is specifically designed for individuals with type 2 diabetes who have not achieved adequate blood sugar control with other medications or lifestyle changes
Doubling the blend dose doubles cost and copper exposure while providing marginal or zero additional benefit
